InSphero is a global leader in scalable, reliable, and reproducible 3D cell culture technology and solutions for drug safety and efficacy testing. Based in Switzerland, the European hub for advancing non-animal drug testing methods, the company has been a trusted partner to major pharmaceutical organizations, academic institutions and regulators since 2009, supporting their efforts to develop safer and faster drug development solutions.

The company’s mission to unlock the full potential of 3D in vitro models is realized through its comprehensive ecosystem of industry-grade technologies and the deep expertise of its scientific and operational teams. Together, they empower researchers to generate biologically and physiologically relevant data, enabling innovation in drug discovery.

News

03.12.2024 Biotech startups celebrate new achievements (startupticker.ch)
05.11.2024 Bio Europe in Stockholm hosts 33 Swiss companies (startupticker.ch)
31.05.2024 Swiss life science startups headed for San Diego (startupticker.ch)
26.11.2020 New prizes and grants from three continents (startupticker.ch)
13.05.2020 Swiss Startups Tackling Corona Virus - COVID-19 (venturelab.swiss)
08.11.2019 IPO Day: Deep-tech companies on stage (startupticker.ch)

Milestones/News

Documents

Videos and Presentations


120 sec introduction to cancer applications of InSphero's 3D InSight™ Tumor Microtissues


90 sec introduction to InSphero's 3D InSight™ Liver Microtissues


InSphero at IFJ


InSphero company video